Ankit Mangla

1.4k total citations
74 papers, 332 citations indexed

About

Ankit Mangla is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ankit Mangla has authored 74 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Ankit Mangla's work include Cutaneous Melanoma Detection and Management (15 papers), Cancer Immunotherapy and Biomarkers (15 papers) and CAR-T cell therapy research (10 papers). Ankit Mangla is often cited by papers focused on Cutaneous Melanoma Detection and Management (15 papers), Cancer Immunotherapy and Biomarkers (15 papers) and CAR-T cell therapy research (10 papers). Ankit Mangla collaborates with scholars based in United States, India and Pakistan. Ankit Mangla's co-authors include Margaret Telfer, Luke D. Rothermel, Pingfu Fu, Michael Russell Mullane, Gary K. Schwartz, Jill S. Barnholtz‐Sloan, John B. Ammori, Jeremy S. Bordeaux, John Hyngstrom and Jingjing Jiang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ankit Mangla

56 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ankit Mangla United States 10 156 73 63 52 45 74 332
Chi Wha Han South Korea 11 141 0.9× 89 1.2× 68 1.1× 62 1.2× 73 1.6× 39 393
Kaan Helvacı Türkiye 9 242 1.6× 105 1.4× 88 1.4× 40 0.8× 23 0.5× 24 371
M. Sinn Germany 9 291 1.9× 102 1.4× 106 1.7× 54 1.0× 29 0.6× 19 517
Michele Pohlen Germany 11 61 0.4× 51 0.7× 87 1.4× 67 1.3× 84 1.9× 18 313
Carrie Ye Canada 10 251 1.6× 56 0.8× 65 1.0× 43 0.8× 22 0.5× 45 393
Sandeep K. Rajan United States 11 107 0.7× 58 0.8× 41 0.7× 46 0.9× 57 1.3× 16 403
Nicola Susca Italy 9 84 0.5× 84 1.2× 21 0.3× 44 0.8× 37 0.8× 20 325
Mariangela Rutigliani Italy 11 109 0.7× 69 0.9× 119 1.9× 50 1.0× 16 0.4× 31 479
Marie‐Bernadette Aretin Austria 6 143 0.9× 63 0.9× 110 1.7× 44 0.8× 10 0.2× 12 419
Wanli Liu China 11 244 1.6× 87 1.2× 78 1.2× 73 1.4× 27 0.6× 18 392

Countries citing papers authored by Ankit Mangla

Since Specialization
Citations

This map shows the geographic impact of Ankit Mangla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankit Mangla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankit Mangla more than expected).

Fields of papers citing papers by Ankit Mangla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankit Mangla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankit Mangla. The network helps show where Ankit Mangla may publish in the future.

Co-authorship network of co-authors of Ankit Mangla

This figure shows the co-authorship network connecting the top 25 collaborators of Ankit Mangla. A scholar is included among the top collaborators of Ankit Mangla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankit Mangla. Ankit Mangla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Rohit, Akihiro Yoshida, Sherry L. Abboud, et al.. (2025). Advances in Oncolytic Viral Therapy in Melanoma: A Comprehensive Review. Vaccines. 13(7). 727–727.
2.
Rao, Rohit, Imran Rashid, M. Zacharias, et al.. (2025). Myocarditis Mimicking Takotsubo Cardiomyopathy With First Dose of Neoadjuvant Nivolumab–Relatlimab. Case Reports in Oncological Medicine. 2025(1). 1443004–1443004.
3.
Patel, Sapna P., Víctor M. Prieto, M. J. S. Lowe, et al.. (2025). 1601O 3-year survival with neoadjuvant-adjuvant pembrolizumab from SWOG S1801. Annals of Oncology. 36. S882–S883.
4.
Hirunpattarasilp, Chanawee, Pingfu Fu, Seunghee Margevicius, et al.. (2025). Outcomes in patients with multiple sclerosis and solid organ cancers treated with immune checkpoint inhibitors. Neuro-Oncology Advances. 7(1). vdaf048–vdaf048.
5.
Chakrabarti, Sakti, et al.. (2025). Safety and Efficacy of Anti–Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic Review. JCO Precision Oncology. 9(9). e2400594–e2400594.
6.
Boone, John M., et al.. (2025). Is Ultrasound-Based Imaging Essential for Melanoma Active Surveillance?. Annals of Surgical Oncology.
7.
Mulligan, Kathleen, et al.. (2024). The Utility of Sentinel Lymph Node Biopsy in Elderly Patients with Melanoma. Annals of Surgical Oncology. 31(12). 8230–8239. 1 indexed citations
8.
Mangla, Ankit, et al.. (2024). Elderberry interaction with pazopanib in a patient with soft‑tissue sarcoma: A case report and literature review. Molecular and Clinical Oncology. 20(5). 36–36.
9.
Kim, J., et al.. (2024). Inhibition of glutaminase elicits senolysis in therapy-induced senescent melanoma cells. Cell Death and Disease. 15(12). 902–902. 4 indexed citations
10.
Mangla, Ankit, Luke D. Rothermel, Shahrazad Saab, et al.. (2024). Neoadjuvant pazopanib with radiation therapy in patients with localized sarcoma: Experience from a sarcoma center.. Journal of Clinical Oncology. 42(16_suppl). e23555–e23555. 1 indexed citations
11.
Mangla, Ankit, et al.. (2024). Desmoid Tumors: Current Perspective and Treatment. Current Treatment Options in Oncology. 25(2). 161–175. 11 indexed citations
12.
Patel, Sapna P., Megan Othus, Paul Wright, et al.. (2023). LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801. Annals of Oncology. 34. S1288–S1288. 7 indexed citations
13.
Hoehn, Richard S., Gary K. Schwartz, Jennifer Cullen, et al.. (2023). Evaluating disruptions in melanoma diagnosis resulting from the COVID-19 pandemic from a community-based perspective. Journal of the American Academy of Dermatology. 90(1). 147–150. 1 indexed citations
14.
Mangla, Ankit, et al.. (2021). Clinical Practice Issues In American Indians and Alaska Natives. StatPearls. 2 indexed citations
15.
Mangla, Ankit, et al.. (2019). Sickle Cell Anemia. StatPearls. 1 indexed citations
16.
Pidikiti, Rajesh, Michael Kharouta, Mark C. Smith, et al.. (2019). Reirradiation for Recurrent Scalp Angiosarcoma: Dosimetric Advantage of PBT over VMAT and EBT. International Journal of Particle Therapy. 6(3). 13–18. 3 indexed citations
17.
Mangla, Ankit, et al.. (2017). Metastasis of cervical cancer to breast: A case report and review of literature. Gynecologic Oncology Reports. 21. 48–52. 10 indexed citations
18.
Mangla, Ankit, et al.. (2015). Alcohol Abuse and Alcoholic Liver Cirrhosis Leading to Spontaneous Muscle Hematoma: An Event Fraught with Danger. Case Reports in Gastroenterology. 9(1). 93–100. 67 indexed citations
19.
Mangla, Ankit, et al.. (2014). Hypotension associated with Advanced Hodgkin Lymphoma. Hematology Reports. 6(3). 5572–5572. 2 indexed citations
20.
Mangla, Ankit, et al.. (2014). Pulmonary arteriovenous malformation: a rare cause of dyspnoea on exertion. BMJ Case Reports. 2014. bcr2014204087–bcr2014204087.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chi Wha Han Breakdown of academic impact, for papers by Kaan Helvacı Breakdown of academic impact, for papers by M. Sinn Breakdown of academic impact, for papers by Michele Pohlen Breakdown of academic impact, for papers by Carrie Ye Breakdown of academic impact, for papers by Sandeep K. Rajan Breakdown of academic impact, for papers by Nicola Susca Breakdown of academic impact, for papers by Mariangela Rutigliani Breakdown of academic impact, for papers by Marie‐Bernadette Aretin Breakdown of academic impact, for papers by Wanli Liu
Rankless by CCL
2026